| Literature DB >> 35699959 |
Ankie Tan Cheung1, William Ho Cheung Li1, Laurie Long Kwan Ho1, Godfrey Chi-Fung Chan2,3, Huen Sum Lam4, Joyce Oi Kwan Chung5.
Abstract
Importance: Physical activity has beneficial effects that mitigate cancer- and treatment-related late effects. However, children who survive cancer are often physically inactive. Brief motivational interviewing may be an effective approach for increasing children's physical activity levels. Objective: To examine the effects of mobile instant messaging-delivered brief motivational interviewing for parents in promoting regular physical activity in children who have survived cancer. Design, Setting, and Participants: An assessor-blinded randomized clinical trial was conducted at 2 Hong Kong pediatric oncology outpatient clinics from March 1, 2019, to January 29, 2021. A total of 161 children who had survived cancer, aged 9 to 16 years, and their parents were randomized (1:1) to an intervention or control group. Interventions: The intervention group received a 6-month mobile instant messaging-delivered brief motivational interviewing using a strategy menu. Parent-child dyads in both groups received a health advice session and were directed to a physical activity website at baseline. Main Outcomes and Measures: The primary outcome was the children's physical activity levels at 12-month follow-up, measured by the Chinese University of Hong Kong: Physical Activity Rating for Children and Youth (total sores: 0-10, higher scores indicate greater physical activity levels). Secondary outcomes were cancer-related fatigue levels, handgrip strength, peak expiratory flow rate, and quality of life. Intention-to-treat analysis was performed.Entities:
Mesh:
Year: 2022 PMID: 35699959 PMCID: PMC9198728 DOI: 10.1001/jamanetworkopen.2022.14600
Source DB: PubMed Journal: JAMA Netw Open ISSN: 2574-3805
Figure 1. Theoretical Framework of the Brief Motivational Interviewing
Attentive to the motivational intervention (MI) spirit of collaboration, compassion, evocation, and acceptance, and the principles of expressing empathy, highlighting discrepancies, avoiding arguments, rolling with resistance, and supporting self-efficacy, this study explored the potential to enhance parents' intrinsic motivation to encourage their child to engage in physical activity (PA) through an MI attuned to their perspectives and ambivalence. The reasoning, in other words, was that the brief MI sessions would support and enhance parents' autonomy and self-efficacy and convince them to motivate their children to be more physically active. Throughout the 4 fundamental processes of brief MI with the adaptation of the menu of strategies and use of micro skills (eliciting and reinforcing preparatory/implementing change talk), it is anticipated that parents' ambivalence toward the engagement in PA for their child will be resolved by exploring both positive and negative aspects of ambivalence (ie, pros and cons of their child performing PA) and their discrepancy in changing the behavior will be developed (indicated by preparatory and implementing change talks). Brief MI could also enhance parents' perceived competency in PA by providing resources and information regarding PA in children who have survived cancer. This probably enables the parents to act as role models in PA behavior and hence proactively motivate their child to adopt and maintain regular PA. The expectation was that PA would improve the children's cancer-related fatigue levels, muscle strength, lung function, and quality of life.
Figure 2. Patient Flow Diagram
T1 indicates 1 month after starting the intervention; T2, 3 months after starting the intervention; T3, 6 months after starting the intervention; and T4, 12 months after starting the intervention.
Demographic, Clinical, and Baseline Characteristics of the Participants
| Characteristic | Group, No. (%) | |
|---|---|---|
| Intervention (n = 81) | Control (n = 80) | |
| Child | ||
| Age, mean (SD), y | 12.3 (2.3) | 12.4 (2.5) |
| Sex | ||
| Male | 44 (54.3) | 49 (61.3) |
| Female | 37 (45.7) | 31 (38.8) |
| Diagnosis | ||
| Leukemia | 31 (38.3) | 27 (33.8) |
| Lymphoma | 19 (23.5) | 21 (26.3) |
| Tumor | ||
| Brain | 20 (24.7) | 15 (18.8) |
| Bone | 8 (9.9) | 10 (12.5) |
| Germ-cell and gonadal | 3 (3.7) | 7 (8.8) |
| Treatment received | ||
| Surgery | 7 (8.6) | 10 (12.5) |
| Chemotherapy | 37 (45.7) | 36 (45.0) |
| Radiotherapy | 1 (1.2) | 2 (2.5) |
| Bone marrow transplant | 5 (6.2) | 3 (3.8) |
| Mixed modality | 31 (38.3) | 29 (36.3) |
| Time since treatment was completed, mo | ||
| 6-12 | 31 (38.3) | 34 (42.5) |
| 13-24 | 12 (14.8) | 12 (15.0) |
| 25-36 | 11 (13.6) | 9 (11.3) |
| 37-48 | 9 (11.1) | 8 (10.0) |
| 49-60 | 18 (22.2) | 17 (21.3) |
| Physical activity levels, mean (SD) | 2.8 (1.2) | 2.8 (1.2) |
| Cancer-related fatigue, mean (SD) | 28.8 (8.8) | 28.7 (8.3) |
| Handgrip strength, mean (SD) | ||
| Left | 16.1 (5.8) | 16.3 (5.8) |
| Right | 18.3 (6.0) | 18.4 (5.8) |
| Peak expiratory flow rate, mean (SD) | 126.1 (40.7) | 127.1 (40.1) |
| Quality of life, mean (SD) | 77.0 (12.6) | 79.1 (14.2) |
| Parents | ||
| Age, mean (SD), y | 43.8 (5.0) | 42.2 (6.1) |
| Sex | ||
| Male | 24 (29.6) | 22 (27.5) |
| Female | 57 (70.4) | 58 (72.5) |
| Parents’ educational level | ||
| Primary school or below | 3 (3.7) | 4 (5.0) |
| Secondary school | ||
| Lower | 20 (24.7) | 19 (23.8) |
| Upper | 35 (43.2) | 41 (51.3) |
| Tertiary education | 23 (28.4) | 16 (20.0) |
Physical activity, measured with the Chinese University of Hong Kong: Physical Activity Rating for Children and Youth. Scores range from 0 to 10 (higher scores indicate greater levels).
Cancer-related fatigue, measured with the Chinese version of the Fatigue Scale: Child. Scores range from 13 to 65 (higher scores indicate greater levels).
Handgrip strength, measured with a handheld dynamometer. Scores range from 0 to 90 kg (higher scores indicate greater handgrip strength).
Peak expiratory flow rate, measured with a mini-Wright Standard Handheld peak flow meter. Scores range from 60 to 880 L/min (higher scores indicate greater peak expiratory flow rate).
Quality of life, measured with the Pediatric QOL Inventory 4.0 Generic Core Scales. Scores range from 0 to 100 (higher scores represent better quality of life).
Generalized Estimating Equation Analysis for the Intervention Effects on the Primary Outcomes
| Primary outcome | Mean (SD) | Group effect | Time effect | Group × time effect | Cohen | ||||
|---|---|---|---|---|---|---|---|---|---|
| Intervention (n = 81) | Control (n = 80) | β (95% CI) | β (95% CI) | β (95% CI) | |||||
| Physical activity levels | |||||||||
| T0 | 2.83 (1.24) | 2.84 (1.22) | 1.95 (1.62 to 2.23) | <.001 | NA | NA | NA | NA | 0.00 |
| T1 | 3.11 (1.22) | 2.68 (1.12) | −0.16 (−0.34 to 0.01) | .07 | −0.15 (−0.51 to 0.21) | .43 | 0.35 | ||
| T2 | 5.21 (1.34) | 2.75 (1.16) | 1.15 (0.92 to 1.39) | <.001 | 2.32 (1.92 to 2.73) | <.001 | 1.99 | ||
| T3 | 6.12 (1.33) | 2.83 (1.22) | 1.53 (1.21 to 1.85) | <.001 | 3.09 (2.65 to 3.53) | <.001 | 2.64 | ||
| T4 | 6.96 (1.37) | 2.69 (1.02) | 1.95 (1.56 to 2.33) | <.001 | 3.91 (3.45 to 4.36) | <.001 | 3.53 | ||
Abbreviations: T0, time of recruitment; T1, 1 month after starting the intervention; T2, 3 months after starting the intervention; T3, 6 months after starting the intervention; T4, 12 months after starting the intervention.
β refers to the estimated coefficient from the multivariate generalized estimating equations models. The β coefficients of the group-by-time interaction terms represent the difference in mean changes in an outcome at a specific time point with respect to the baseline (T0) between the intervention and control groups (mean change in intervention group − mean change in control group). A positive group-by-time interaction coefficient indicates a greater mean change in intervention group compared with control group.
Physical activity, measured with the Chinese University of Hong Kong: Physical Activity Rating for Children and Youth. Scores range from 0 to 10 (higher scores indicate greater levels).
Generalized Estimating Equation Analysis for the Intervention Effects on the Secondary Outcomes
| Secondary outcomes | Mean (SD) | Group effect | Time effect | Group × time effect | Cohen | ||||
|---|---|---|---|---|---|---|---|---|---|
| Intervention (n = 81) | Control (n = 80) | β (95% CI) | β (95% CI) | β (95% CI) | |||||
| Cancer-related fatigue | |||||||||
| T0 | 28.78 (8.79) | 28.66 (8.26) | −3.60 (−5.97 to −1.24) | .003 | NA | NA | NA | NA | NA |
| T1 | 28.20 (8.40) | 29.06 (8.24) | −0.09 (−0.28 to 0.09) | .32 | −0.47 (−3.04 to 2.11) | .72 | 0.11 | ||
| T2 | 26.02 (7.71) | 28.82 (8.25) | −1.40 (−1.83 to −0.96) | <.001 | −2.71 (−5.16 to −2.52) | <.001 | 0.34 | ||
| T3 | 22.89 (6.85) | 28.50 (8.12) | −3.01 (−3.64 to −2.37) | <.001 | −5.69 (−8.03 to −3.35) | <.001 | 0.74 | ||
| T4 | 19.49 (5.65) | 28.44 (8.39) | −4.84 (−5.80 to −3.89) | <.001 | −9.16 (−11.31 to −7.00) | <.001 | 1.24 | ||
| Left-hand grip strength | |||||||||
| T0 | 16.14 (5.79) | 16.30 (5.75) | 1.78 (0.05 to 3.44) | .04 | NA | NA | NA | NA | 0.03 |
| T1 | 16.30 (5.80) | 16.29 (5.76) | 0.07 (0.04 to 0.10) | <.001 | 0.004 (−1.78 to 1.79) | >.99 | 0.00 | ||
| T2 | 17.26 (5.75) | 16.44 (5.74) | 0.58 (0.45 to 0.71) | <.001 | 1.04 (−0.75 to 2.83) | .25 | 0.16 | ||
| T3 | 19.09 (5.79) | 16.47 (5.78) | 1.46 (1.02 to 1.91) | <.001 | 2.69 (0.96 to 4.43) | .002 | 0.45 | ||
| T4 | 22.16 (6.29) | 16.72 (5.79) | 2.88 (2.16 to 3.60) | <.001 | 5.52 (3.70 to 7.33) | <.001 | 0.91 | ||
| Right-hand grip strength | |||||||||
| T0 | 18.29 (5.99) | 18.40 (5.77) | 2.11 (0.40 to 3.82) | .02 | NA | NA | NA | NA | 0.02 |
| T1 | 18.52 (5.95) | 18.39 (5.76) | 0.10 (0.04 to 0.17) | <.001 | 0.11 (−1.69 to 1.92) | .90 | 0.02 | ||
| T2 | 19.43 (6.00) | 18.42 (5.75) | 1.59 (1.30 to 1.88) | <.001 | 2.79 (0.98 to 4.60) | .002 | 0.17 | ||
| T3 | 21.28 (5.75) | 18.60 (5.81) | 1.49 (1.07 to 1.91) | <.001 | 2.75 (1.01 to 4.50) | .002 | 0.47 | ||
| T4 | 24.29 (6.16) | 18.90 (5.89) | 2.87 (2.13 to 3.61) | <.001 | 5.45 (3.62 to 7.27) | <.001 | 0.89 | ||
| Peak expiratory flow rate | |||||||||
| T0 | 126.11 (40.70) | 127.06 (40.05) | 6.48 (−5.49 to 18.45) | .29 | NA | NA | NA | NA | 0.02 |
| T1 | 126.60 (41.12) | 127.38 (39.63) | 0.40 (−0.13 to 0.94) | .14 | −0.46 (−12.92 to 12.00) | .94 | 0.02 | ||
| T2 | 130.89 (40.64) | 127.59 (39.65) | 2.64 (1.74 to 3.53) | <.001 | 3.82 (−8.69 to 16.34) | .55 | 0.08 | ||
| T3 | 139.55 (40.21) | 128.94 (39.20) | 3.01 (3.95 to 39.78) | <.001 | 4.33 (−8.05 to 16.71) | .49 | 0.27 | ||
| T4 | 156.91 (41.32) | 130.82 (39.52) | 15.38 (11.09 to 19.66) | <.001 | 28.51 (16.10 to 40.92) | <.001 | 0.65 | ||
| Quality of life | |||||||||
| T0 | 77.00 (12.58) | 79.14 (14.19) | 4.00 (0.25 to 7.74) | .04 | NA | NA | NA | NA | 0.16 |
| T1 | 78.60 (12.47) | 78.64 (14.08) | 0.55 (0.29 to 0.82) | <.001 | −0.55 (−4.65 to 3.56) | .79 | 0.00 | ||
| T2 | 79.79 (12.19) | 78.53 (13.95) | 1.12 (0.75 to 1.63) | <.001 | 3.81 (−3.26 to 4.87) | .70 | 0.10 | ||
| T3 | 83.73 (10.84) | 78.77 (13.63) | 3.40 (2.63 to 4.17) | <.001 | 5.01 (1.19 to 8.82) | .01 | 0.40 | ||
| T4 | 93.30 (6.07) | 78.21 (13.77) | 7.71 (5.99 to 9.44) | <.001 | 14.19 (10.84 to 17.54) | <.001 | 1.42 | ||
Abbreviations: T0, time of recruitment; T1, 1 month after starting the intervention; T2, 3 months after starting the intervention; T3, 6 months after starting the intervention; T4, 12 months after starting the intervention.
β refers to the estimated coefficient from the multivariate generalized estimating equations models. The β coefficients of the group-by-time interaction terms represent the difference in mean changes in an outcome at a specific time point with respect to the baseline (T0) between the intervention and control groups (mean change in intervention group − mean change in control group). A positive group-by-time interaction coefficient indicates a greater mean change in intervention group compared with control group.
Fatigue, measured with the Chinese version of the Fatigue Scale: Child. Scores range from 13 to 65 (higher scores indicate greater levels).
Handgrip strength, measured with a handheld dynamometer. Scores range from 0 to 90 kg (higher scores indicate greater handgrip strength).
Peak expiratory flow rate, measured with a mini-Wright Standard Handheld peak flow meter. Scores range from 60 to 880 L/min (higher scores indicate greater peak expiratory flow rate).
Quality of life, measured with the Pediatric QOL Inventory 4.0 Generic Core Scales. Scores range from 0 to 100 (higher scores represent better quality of life).